# OASMIA PHARMACEUTICAL AB (OASMY)

> Institutional ownership reported to the SEC as of Q2 2019, from Form 13F filings. Source: https://holderbook.com/stocks/OASMY/

- Reporting holders: 3
- Reported value: $38.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Compagnie Lombard Odier SCmA](https://holderbook.com/funds/1615423-compagnie-lombard-odier-scma/) | $33.0K | 33,300 | 0.0% | 3 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $3.0K | 2,723 | 0.0% | 3 |
| [FNY Investment Advisers, LLC](https://holderbook.com/funds/1742998-fny-investment-advisers-llc/) | $2.0K | 2,600 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2019 | 3 | $38.0K |
| Q1 2019 | 6 | $187.0K |
| Q4 2018 | 4 | $323.0K |